COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.76
+2.90% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
19.51
P/S ratio
1.40x
EPS (TTM)
$1.73
Dividend yield
—
52W range
$27 – $51
Volume
0.6M
Collegium Pharmaceutical Inc (COLL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.05%
Operating margin
30.00%
ROE
23.70%
ROA
7.27%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-16.20M | — | — | — |
| 2014 | $0.00 | $-17.92M | — | — | — |
| 2015 | $0.00 | $-27.25M | — | — | — |
| 2016 | $1.71M | $-94.18M | 87.55% | -5,498.66% | -5,504.15% |
| 2017 | $28.48M | $-74.86M | 90.89% | -264.95% | -262.91% |
| 2018 | $280.41M | $-39.13M | 40.92% | -7.38% | -13.95% |
| 2019 | $296.70M | $-22.72M | 34.73% | -8.00% | -7.66% |
| 2020 | $310.02M | $26.75M | 58.01% | 18.14% | 8.63% |
| 2021 | $276.87M | $71.52M | 54.40% | 6.37% | 25.83% |
| 2022 | $463.93M | $-25.00M | 45.15% | 7.18% | -5.39% |
| 2023 | $566.77M | $48.16M | 57.55% | 29.46% | 8.50% |
| 2024 | $631.45M | $69.19M | 59.76% | 26.91% | 10.96% |
| 2025 | $780.57M | $62.87M | 59.35% | 23.97% | 8.05% |